Shire’s Ornskov Not Planning Quick Hires To Fill Top Leadership Ranks
This article was originally published in The Pink Sheet Daily
Executive Summary
Incoming Shire CEO Flemming Ornskov made his debut before the rare disease community by delivering a keynote address at the World Orphan Drug Congress. Afterwards, he talked about the management transition at his new company and challenges in orphan drug development.